IM Cannabis Corp. Files 6-K with Corporate Updates

TL;DR

IM Cannabis Corp. dropped a 6-K on July 1st with corporate updates, filed as Exhibit 99.1 and linked to their F-3 registration.

AI Summary

On July 1, 2025, IM Cannabis Corp. issued a press release providing corporate updates. The press release is furnished as Exhibit 99.1 to this Form 6-K filing. This report is incorporated by reference into the Company's registration statement on Form F-3 (File No. 333-288346).

Why It Matters

This filing indicates that IM Cannabis Corp. is providing important corporate information to the SEC, which may affect investor understanding of the company's current status.

Risk Assessment

Risk Level: low — This filing is a routine report of corporate updates and does not appear to contain significant new financial or operational information that would immediately alter risk.

Key Players & Entities

• IM Cannabis Corp. (company) — Registrant
• July 1, 2025 (date) — Date of press release and filing
• Exhibit 99.1 (document) — Press release furnished
• Form F-3 (document) — Registration statement
• 333-288346 (document) — File number for registration statement

FAQ

From the Filing

0001178913-25-002270.txt : 20250701 0001178913-25-002270.hdr.sgml : 20250701 20250701085724 ACCESSION NUMBER: 0001178913-25-002270 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250701 FILED AS OF DATE: 20250701 DATE AS OF CHANGE: 20250701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251094279 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533405.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of July 2025   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   CONTENTS   On July 1, 2025, IM Cannabis Corp. (the “Company”) issued a press release titled: “IM Cannabis Corp. Provides Corporate Updates”. A copy of this press release is furnished herewith as Exhibit 99.1.   This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s registration Statement on Form F-3 (File No. 333-288346) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   EXHIBIT INDEX   Exhibit No.   99.1 Press Release dated July 1, 2025 “IM Cannabis Corp. Provides Corporate Updates”.     SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date: July 1, 2025 By: /s/ Oren Shuster   Name:     Oren Shuster   Title: Chief Executive Officer and Director EX-99.1 2 exhibit_99-1.htm EXHIBIT 99-1 Exhibit 99.1 IM Cannabis Provides Corporate Updates   TORONTO and GLIL YAM, Israel, July 1, 2025/CNW/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the “ Company ”, “ IM Cannabis ”, or “ IMC ”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates.   As previously reported on April 11, 2025, the Company received a deficiency letter (the “ Nasdaq Letter ”) on April 9, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (the “ Nasdaq ”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “ Stockholders’ Equity Requirement ”), nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.   On May 23, 2025, the Company submitt